SEARCH
 
Home   Suggestions   Enquiry   Advertise with us
Wednesday, December 7, 2022
 
NEWS COVAXIN
Read News in
 

| 1 | 2 | More Topics on COVAXIN...

Covaxin can help control virus load, reduce disease severity: Study
New Delhi |Saturday, 2022 5:15:09 AM IST
Scientists have found that Covaxin, which is an inactivated whole-virion vaccine, induces robust immune memory to SARS-CoV-2 and its variants of concern that persists for at least six months after vac read..


 
Bharat Biotech seeks nod for Covaxin booster trials for 2-18 age group
New Delhi |Thursday, 2022 4:15:10 AM IST
Hyderabad-based vaccine manufacturer Bharat Biotech has sought permission to conduct booster dose trials of its Covid vaccine Covaxin for below 18 population. read..


 
Restricted emergency use approvals to Covishield, Covaxin not granted in haste: SC
New Delhi |Tuesday, 2022 3:45:10 AM IST
The Supreme Court on Monday said the material provided by the Centre does not warrant the conclusion that restricted emergency use approvals were granted to Covishield and Covaxin in haste, without th read..


 
Bharat Biotech upgrading facilities as WHO suspends Covaxin supplies
New Delhi/Hyderabad |Monday, 2022 3:45:09 AM IST
After the World Health Organisation (WHO) suspended the supply of Bharat Biotech's Covaxin vaccine under the United Nations (UN) procurement after an inspection last month, the company has said it is read..


 
Covaxin underwent all necessary trials, findings widely published, SC told
New Delhi |Wednesday, 2022 1:15:10 AM IST
Bharat Biotech International Ltd has told the Supreme Court that Covaxin has undergone all necessary clinical trials and the Phase 3 efficacy trials revealed the vaccine is 77.8 per cent effective aga read..


 
Covishield, Covaxin cleared for regular market approval
New Delhi |Thursday, 2022 5:15:07 AM IST
India's two main vaccines -- Bharat Biotechs Covaxin and Serum Institute of India's Covishield -- on Wednesday got the nod for regular market authorisation. read..


 
Ensure only Covaxin is given to 15-18 group: Bharat Biotech
Hyderabad |Wednesday, 2022 2:45:07 AM IST
Bharat Biotech has urged healthcare workers to ensure that only Covaxin is administered to individuals in the 15-18 years age group. read..


 
Covaxin booster dose trial shows 'long-term safety': Bharat Biotech
New Delhi |Sunday, 2022 3:15:07 AM IST
Hyderabad-based vaccine manufacturer Bharat Biotech said on Saturday that its trials for Covaxin booster dose have shown 'long-term safety with no serious adverse events'. read..


 
Paracetamol not recommended after getting Covaxin jab: Bharat Biotech
Hyderabad |Thursday, 2022 3:45:08 AM IST
Vaccine maker Bharat Biotech on Wednesday clarified that Paracetamol or pain killers are not recommended for teenagers after being vaccinated with Covaxin. read..


 
India supplies 5 lakh Covaxin doses to Afghanistan
New Delhi |Saturday, 2022 9:15:08 PM IST
India supplied humanitarian assistance consisting of 5,00,000 Covaxin doses to Afghanistan on Saturday, the Ministry of External Affairs said. read..


 
33.2 lakh students in TN to be given Covaxin from Jan 3
Chennai |Saturday, 2022 4:15:08 PM IST
Tamil Nadu health department will be inoculating 33.2 lakh students with Covaxin from January 3 onwards. read..


 
Covaxin for children proven to be safe in paediatric subjects in study: Bharat Biotech
New Delhi |Friday, 2021 2:15:08 AM IST
Hyderabad based vaccine manufacturer Bharat Biotech on Thursday announced that BBV152 (Covaxin), its whole-virion inactivated COVID-19 vaccine candidate, has proven to be safe, well-tolerated, and imm read..


 

| 1 | 2 | More Topics on COVAXIN...

 
 
 
 
SocialTwist Tell-a-Friend
 
NEWS VIDEOS
 
TOP NEWS WORLD ASIA
Woman YouTuber arrested for extorting Rs...
Controversy over Malayalam film title 'H...
Inorganic food additives can make babies...
Mathura on high alert, after ABHM calls ...
More...    
 
 
 
TRENDING TOPICS
 
 
CITY NEWS
     
 
 
 ARCHIVES
 
News:
 
 

Copyright 2000 - 2022 Suni System (P) Ltd. All rights reserved